The financials
Illumina, Inc. by the numbers
Illumina, Inc. (ILMN) reported revenue of $1.16B in Q2 2026 (quarter ended Jun 28, 2026), up 9.4% from the same quarter a year earlier. That came with a gross margin of 66% and net income of $207M (18% of revenue). For the full year FY2025, revenue was $4.34B (−0.7% year on year) and net income $850M. Its largest region in Q2 2026 was United States And Canada at $653M, 56% of the disclosed total, well ahead of EMEA at 32%.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Revenue | $1.16B | $1.06B | +9.4% |
| Gross profit | $770M | $695M | +11% |
| Operating income | $245M | $214M | +14% |
| Net income | $207M | $235M | −12% |
| Diluted EPS | $1.35 | $1.49 | −9.4% |
| Geographic | Revenue | Share |
|---|---|---|
| United States And Canada | $653M | 56% |
| EMEA | $368M | 32% |
| Asia Pacific | $82M | 7.1% |
| China | $56M | 4.8% |
Business Segments
Revenue split by geographic segment, from SEC XBRL filings.
Latest period: Q2 2026Total $1.16B (+6.2%)
United States And Canada grew +15% year on yearChina -11% year on year
Segment Latestquarter on quarteryear on year
- United States And Canada$653.0M$653.0MQoQ +11%year on year +15%+11%+15%
- EMEA$368.0M$368.0MQoQ +3.4%year on year +3.7%+3.4%+3.7%
- Asia Pacific$82.0M$82.0MQoQ -12%year on year +14%-12%+14%
- China$56.0M$56.0MQoQ +7.7%year on year -11%+7.7%-11%
Diagnostics & Research
Ranks #7 of 17 by Smart Score